Patient Dies After Gene Editing Trial in China
A patient with Duchenne muscular dystrophy died after receiving a gene editing therapy from Shanghai-based HuidaGene Therapeutics, the company said on Wednesday. The death occurred in August 2025 and was attributed to…
